Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells

Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells

US Patent 10383932 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SARS-CoV-2 fusion protein vaccine/regimen2025
Combination cancer therapy2023
Burkholderia pseudomallei composition2021
Composition and method against tuberculosis2021
CD40 ligand fusion protein vaccine2021
Adenoviral vector vaccine2021
Vaccine directed to induction of immune response to protein and glycolipid antig2020
Dengue hemorrhagic fever virus vaccine2019
Pharmaceutical compositions and methods of blocking Bacillus anthracis2019
TAA/CD4OL composition/vaccine for malaria2019
Multivalent DNA composition for Yersinia pestis2019
Vaccines for herpes simplex virus 1 and 22019